AIM: To observe the effect of erythropoietin( EPO) on the quality of life and hospitalization time in patients with chronic heart failure( CHF). METHODS: Eighty CHF patients were randomly equally divided into two groups: 40 patients in the control group treated with standard CHF medications and 40 patients in the EPO group treated with standard CHF medications plus EPO. The Minnesota Heart Failure Quality of Life Scale was measured before and after treatment and hospitalization days and rates of re-hospital...